Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 1, 2014
Xanthomas: clinical and pathophysiological relationsAles Zak, Miroslav Zeman, Adolf Slaby, et al.
Neuro Endocrinology Letters|November 28, 2012
N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemiaMarek Vecka, Magdalena Dušejovská, Barbora Stankova, et al.
Neuro Endocrinology Letters|February 9, 2013
N-3 polyunsaturated fatty acids in psychiatric diseases: mechanisms and clinical dataMiroslav Zeman, Roman Jirak, Marek Vecka, et al.
Neuro Endocrinology Letters|October 27, 2009
Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive womenMiroslav Zeman, Roman Jirak, Marie Jachymova, et al.
Neuro Endocrinology Letters|November 28, 2012
Plasma fatty acid profile in depressive disorder resembles insulin resistance stateTomas Vareka, Marek Vecka, Roman Jirak, et al.
Acta Universitatis Carolinae. Medica. Monographia|March 17, 2009
Noncholesterol sterolsMarek Vecka, Ales Zak, Eva Tvrzická
Casopis Lekaru Ceskych|March 27, 2012
[Statin-ezetimibe combination in hyperlipidemia treatment]Tomás Vareka, Daniela Vítková, Miroslav Zeman, et al.
Metabolic Syndrome and Related Disorders|May 13, 2021
Altered Indices of Fatty Acid Elongases ELOVL6, ELOVL5, and ELOVL2 Activities in Patients with Impaired Fasting GlycemiaJaroslav Macášek, Miroslav Zeman, Aleš Žák, et al.
Metabolic Syndrome and Related Disorders|March 12, 2020
Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic RiskMarek Vecka, Aleš Žák, Eva Tvrzická, et al.
The Journal of Nutritional Biochemistry|October 11, 2005
N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combinationMiroslav Zeman, Ales Zák, Marek Vecka, et al.
Pageof 7